All articles by Sarah Houlton – Page 8
-
News
Sanofi to buy Genzyme in $20 billion deal
Sanofi-Aventis wins over Genzyme board with $1.5 billion increase to August 2010 bid
-
News
Fines, flu and an uncertain future
Our roundup of another tough year for the pharma industry takes a closer look at the big players hit by big fines
-
Careers
The insider: Chemical public relations
It's not all personalised number plates and designer sun glasses; there's a serious side to PR too, discovers Sarah Houlton
-
News
U-turn on Alzheimer's drugs in the UK
UK body is poised to reverse a 2007 decision preventing NHS patients in the UK receiving a number of acetylcholinesterase drugs for Alzheimer's disease
-
Careers
Profile: Sustainable chemist
Matthew Davidson, professor of sustainable chemical technologies, talks to Sarah Houlton about the University of Bath's new Centre for Sustainable Chemical Technologies
-
News
Plastic oceans
Despite the rise in plastic production, the amount of debris in the ocean may not be increasing
-
Feature
Saudi science breaks the mould
Sarah Houlton speaks to research pioneers at the King Abdullah University of Science and Technology as it approaches its first anniversary
-
Careers
Profile: Nurturing industrial collaboration
Organic chemist Joe Sweeney is developing a collaborative network with industry that looks set to provide a new model for knowledge and innovation exchange, says Sarah Houlton
-
News
Antibodies spark HIV vaccine hopes
New antibodies against HIV could point the way to an effective vaccine against the virus
-
News
Austerity measures hit higher education
Funding and support for student places hit as universities feel the effects of government plans to cut the budget deficit
-
News
A smaller future for big pharma?
GlaxoSmithKline chief executive Andrew Witty warns cuts to spending on medicines could affect efforts to discover new drugs in the future
-
News
EU ministers call for nanomaterial ban
MEPs submit proposals for nanosilver and carbon nanotubes to be banned in electronic products
-
News
EPA and pharma join forces
US Environmental Protection Agency hooks up with pharma companies to use failed drugs to improve its ToxCast toxicity prediction tool
-
News
UK under new management
The UK finally has a government - but what will the Tory-Lib Dem coalition mean for science?
-
News
EU research faces radical overhaul
Radical changes to EU research funding policies as European Commission responds to calls to cut red tape
-
Careers
Managing change: Returning to academia
The US National Science Foundation is encouraging women back to academic positions, writes Sarah Houlton
-
News
Fresh hep C hope
A new treatment for hepatitis C could be around the corner as a novel compound is proving to be a potent inhibitor of the virus
-
News
Lords call for research funding clarity
The House of Lords Science and Technology Committee has called on the UK government to clarify its research funding commitments